Goelzer Investment Management Inc. Grows Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Goelzer Investment Management Inc. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the fourth quarter, HoldingsChannel reports. The firm owned 6,412 shares of the medical equipment provider’s stock after purchasing an additional 91 shares during the period. Goelzer Investment Management Inc.’s holdings in Intuitive Surgical were worth $3,347,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the stock. LVW Advisors LLC increased its holdings in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares during the last quarter. Wesbanco Bank Inc. grew its position in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after acquiring an additional 19 shares during the period. Hazlett Burt & Watson Inc. increased its stake in Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after acquiring an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. raised its position in Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares during the period. Finally, Fragasso Financial Advisors Inc lifted its stake in shares of Intuitive Surgical by 3.0% in the 4th quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock valued at $359,000 after purchasing an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, CFO Jamie Samath sold 108 shares of the stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,475 shares of company stock worth $22,070,807. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 4.0 %

Shares of NASDAQ:ISRG opened at $584.05 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock has a market cap of $208.03 billion, a price-to-earnings ratio of 93.90, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The firm’s 50 day moving average price is $546.03 and its 200 day moving average price is $503.38.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on ISRG shares. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. Raymond James lifted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday. Finally, JPMorgan Chase & Co. upped their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $583.83.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.